Kate Farms raises $51m in Series B round for plant-based liquid nutrition products

TAGS

Kate Farms, a US-based medical nutrition company, has raised $51 million in a Series B funding round, led by Goldman Sachs, for advancing its mission of making plant-based liquid nutrition available for all in need.

Kaiser Permanente Ventures and existing individual investors also participated in the funding round.

Allison Berardo – a Vice President in Goldman Sachs’ growth equity platform GS Growth said: “We are excited to be backing the Kate Farms team as they continue to pave the way for plant-based nutrition in healthcare.

See also  Retail tech startup Accel Robotics raises $30m from SoftBank and others

“Kate Farms’ differentiated product, strong community support from both patients and providers, and widespread distribution make them a true category leader within the overall liquid nutrition industry.”

Kate Farms is engaged in producing plant-based, organic, clinically proven formulas for tube feeding to help nourish people with chronic illnesses.

The medical nutrition company also makes nutrition shakes that are orally consumed for people having shorter-term or milder conditions that don’t need tube feeding.

Kate Farms raises $51m in Series B round for plant-based liquid nutrition products

Kate Farms raises $51m in Series B round for plant-based liquid nutrition products. Photo courtesy of Kate Farms.

Prepared without major allergens, the product portfolio is USDA Organic-certified, vegan, gluten-free and kosher, and is said to be accessible in more than 95% of hospitals in the US.

See also  Gilead Sciences names Lilly senior VP Christi L. Shaw as Kite CEO

Kate Farms formulas and nutrition shakes are said to be prepared from easily digested organic pea protein, prebiotic soluble fiber from organic agave inulin, and a clinically effective phytonutrient blend that provides antioxidants.

Brett Matthews – Chairman and CEO of Kate Farms said: “Kate Farms’ mission has always been to make nutrition the foundation of health so that people can live their best lives. We know first-hand that plant-based nutrition can reverse disease and prevent illness and are excited to be working alongside some of the leading hospitals, doctors and dietitians to provide a higher standard of nutrition for people with medical conditions.

See also  Pernod Ricard acquires Castle Brands for $223m

“Now with the addition of our new Blue-Chip investors, we will continue to accelerate our efforts to lead the plant-based revolution in healthcare to help the hundreds of millions of people who can benefit.”

CATEGORIES
TAGS
Share This